Your Top 50 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
First-Line Nivolumab Plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer (CheckMate 568): Outcomes by Programmed Death Ligand 1 and Tumor Mutational Burden as Biomarkers
Neal Ready, Matthew David Hellmann, Mark Magdi Awad, Gregory A. Otterson, Martin E Gutierrez, Justin F. Gainor and 22 more
- Rank
- 19 of 507
- Percentile
- top 3.8%
- Where
- Journal of Clinical Oncology, 2019
- Citations
- 583
From the 2019 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.